Related Experiment Video
Updated: Jun 29, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Nitric oxide-mediated pathogenesis during nicotine and alcohol consumption
1Division of Physiology, Faculty of Health, Birmingham City University, 701 Baker Building, Franchise Street, Perry Barr, Birmingham B42 2SU, U.K. rgcooperuk@yahoo.com
This review explores how alcohol and tobacco impact health through nitric oxide (NO) pathways. Understanding these effects is crucial for managing alcohol- and tobacco-related diseases and improving quality of life.
Area of Science:
- Physiology
- Pathophysiology
- Molecular Biology
Background:
- Nitric oxide (NO) is a key signaling molecule produced by various cells in response to physiological and pathophysiological stimuli.
- Alcohol and tobacco consumption have significant pathophysiological effects on organ function.
- Nitric oxide-mediated mechanisms appear to play a direct role in the progression of alcohol- and tobacco-related diseases.
Purpose of the Study:
- To review the impact of alcohol and tobacco intake on health.
- To elucidate the role of nitric oxide (NO) in the adverse effects of alcohol and tobacco.
- To provide insights into how these substances affect quality of life.
Main Methods:
- Literature review of studies on nitric oxide, alcohol, and tobacco.
- Analysis of the pathophysiological effects of nicotine and alcohol on organ systems.
- Examination of NO-mediated mechanisms in disease progression.
Main Results:
- Nicotine adversely affects blood vessel function, promotes atherosclerosis via enhanced cytokine production and NF-kB activation.
- Alcohol induces NO production, accelerating neutrophil apoptosis and sensitizing the liver to endotoxemic shock.
- Elevated NO levels and nitrosative stress contribute to tumor growth.
Conclusions:
- Alcohol and tobacco intake significantly influence health outcomes through NO-mediated pathways.
- Understanding these NO-driven mechanisms is vital for disease management and improving quality of life for affected individuals.
Related Concept Videos
Nitric Oxide Signaling Pathway
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Coronary Artery Disease II: Pathophysiology
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

